About Jason Whitmire
Form D filings for Cytosolix in 2023 list Jason Whitmire as director.
Jason Whitmire first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Jason Whitmire in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Jason Whitmire works with at each company, as listed on that company's latest Form D.
Cytosolix, Inc. · Form D, Jun 28, 2023
JD
John Deacon
Executive officer and director
CF
Colin Foster
Chief Executive Officer and director
AB
Alex Brunicki
Director